1. Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma. Issue 4 (12th May 2022) Authors: Wolfe, Zachary; Friedland, Julie C.; Ginn, Sarah; Blackham, Aaron; Demberger, Lauren; Horton, Morgan; McIntosh, Alyson; Sheikh, Hina; Box, Jessica; Knoerzer, Deborah; Federowicz, Bryan; Stuhlmiller, Timothy J.; Shapiro, Mark; Nair, Suresh Journal: Melanoma research Issue: Volume 32:Issue 4(2022) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗